Page 506 - Small Animal Internal Medicine, 6th Edition
P. 506

478    PART III   Digestive System Disorders


            (e.g., hetastarch). Plasma has antibodies that are presumed   immunized. Inactivated vaccines generally are not as suc-
            to be beneficial, but there is no evidence that they affect   cessful as attenuated vaccines, and giving a series of vaccina-
  VetBooks.ir  outcome. Colloids are typically preferred because they are   tions  is  recommended.  Attenuated vaccines  are  more
                                                                 successful in producing a long-lasting immunity. Typically,
            less expensive and more effective in raising plasma oncotic
            pressure. Antibiotic therapy is necessary if there is evidence
                                                                 age is usually successful. If the initial vaccination is after 16
            of infection (i.e., fever, SIRS) or increased risk of infection   administering an attenuated vaccine at 6, 9, and 12 weeks of
            (i.e., severe neutropenia). If the animal is neutropenic but   weeks of age, then two doses 2 to 4 weeks apart suffice. If
            afebrile, administration of a first-generation cephalosporin   vaccination is before 5 to 6 weeks of age, an inactivated
            is  reasonable  for  prophylaxis.  If  the  animal  is  in  SIRS,  an   vaccine is safer. After the initial series, one booster between
            antibiotic combination with a broad aerobic and anaerobic   6 to 12 months of age is recommended. Revaccination every
            spectrum is recommended (e.g., ampicillin plus either ami-  3 years should be sufficient after the initial series and first
            kacin or enrofloxacin). Aminoglycosides should not be   booster. There is no strong evidence that parvoviral vaccina-
            administered until the patient is rehydrated and renal perfu-  tion should be given separately from modified live canine
            sion is reestablished. Administering enrofloxacin to young,   distemper vaccinations. However, modified live vaccinations
            large-breed dogs may damage cartilage, but this is preferable   should not be administered to patients younger than 5 weeks
            to death. Severe vomiting complicates therapy and may   of age or those suspected of incubating or being affected with
            require administration  of  maropitant  or ondansetron  (see   distemper. Vaccination with CPV-2b virus protects against
            Table 28.3). Maropitant seems to help alleviate visceral pain   infection with CPV-2c. If necessary, serum antibody titers
            in addition to being an effective antiemetic. If these drugs   (which are assumed to be protective) may be measured to
            are ineffective, then combining them with constant rate infu-  determine if the vaccination appeared to be effective. Regard-
            sion of metoclopramide often enhances efficacy. If esophagi-  less of the vaccine or protocol used, there is no guarantee of
            tis occurs, a proton pump inhibitor may be useful (see Table   success. Parvoviral enteritis has occurred in supposedly well-
            28.4). Human granulocyte colony-stimulating factor (G-CSF,   vaccinated dogs.
            5 µg/kg SQq24h) to increase neutrophil numbers, Tamiflu   If parvoviral enteritis develops in one dog in a multiple-
            (oseltamivir phosphate, 2 mg/kg orally [PO] q12-24h) to   dog household, it is reasonable to administer booster vac-
            combat the virus, and equine antiendotoxin serum have   cinations to the other dogs, preferably using an inactivated
            been advocated, but there is no evidence that they substan-  vaccine in case they are incubating the infection at the time
            tively affect outcome. Flunixin meglumine has been anecdot-  of immunization. If the client is bringing a puppy into a
            ally suggested for patients in SIRS, but there is substantial   house with a dog that has recently had parvoviral enteritis,
            risk of iatrogenic ulceration and/or perforation. There is   the puppy should be kept elsewhere until it has received its
            some evidence that recombinant feline interferon omega   immunizations.
                            6
            (rFeIFN-ω, 2.5 × 10  units/kg IV) improves outcome, but it
            is not readily available.                            Prognosis
              If possible, feeding small amounts of liquid diet via a   Dogs treated in a timely fashion with proper therapy typi-
            nasoesophageal (NE) tube seems to help the intestines heal   cally live, especially if they survive the first 4 days of clinical
            more rapidly. An easily digested diet may be fed once vomit-  signs. Intussusception secondary to parvoviral enteritis may
            ing has ceased. Parenteral nutrition can benefit patients that   cause persistent diarrhea in pups otherwise recovering. Dogs
            are persistently unable to hold down oral food. Partial par-  that have recovered from CPV-2 enteritis develop long-lived
            enteral nutrition (also called peripheral parenteral nutrition)   immunity that may be lifelong.
            is easier and less expensive than total parenteral nutrition.
            The dog should be kept away from other susceptible animals   FELINE PARVOVIRAL ENTERITIS
            for 2 to 4 weeks after discharge, and the owner should be
            conscientious about feces disposal. Vaccination of other dogs   Etiology
            in the household should be considered.               Feline parvoviral enteritis (feline distemper, feline panleu-
              When trying to prevent the spread of parvoviral enteritis,   kopenia) is caused by feline panleukopenia virus (FPV),
            the clinician must remember that (1) parvovirus persists in   which is distinct from CVP-2b. However, CPV-2a, CPV-2b,
            the environment for long periods of time (i.e., months),   and CPV-2c can infect cats and cause disease. Kittens
            making  it  difficult  to  prevent  exposure;  (2)  asymptomatic   need to be vaccinated after 12 weeks of age to ensure
            dogs may shed virulent CPV-2; (3) maternal immunity suf-  protection.
            ficient to inactivate vaccine virus may be present in some
            puppies; and (4) dilute bleach (1 : 32) is one of the few readily   Clinical Features
            available disinfectants that kills the virus, but it can take 10   Many infected cats never show clinical signs of disease. Signs
            minutes to be effective.                             in affected cats are usually similar to those described for dogs
              Vaccination of pups should generally commence at 6 to 8   with parvoviral enteritis. If a pregnant queen is infected, the
            weeks of age. The antigen density and immunogenicity of the   result may be abortion or congenital abnormalities. If the
            vaccine as well as the amount of antibody transferred from   fetus is infected later in pregnancy or immediately after
            the bitch determine when the pup can be successfully   birth, cerebellar hypoplasia may result.
   501   502   503   504   505   506   507   508   509   510   511